Form 4 · Filed Jul 11, 2026, 12:00 AM UTC
APGE/Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | G | other | 75,046 | $0 | $0 | 920,941 |
| Jul 8, 2026 | S | sell | 20,000 | $134 | $2,672,600 | 995,987 |
Source: SEC EDGAR raw filing ↗ · Accession 0001104659-26-082758